Fox Biosystems
  • Home
  • Technology
    • Technology
    • Proteins and antibodies
    • Crude Samples
    • Bioprocess
    • Cells and Microvesicles
    • Other Applications
  • Products and services
    • Products and services
    • White FOx 1.0
    • Services
  • ABOUT FOX
    • The company
    • Projects and Partnerships >
      • Link2Innovate
    • Management and founders
    • Careers >
      • Manufacturing Technician Biosensors
  • NEWS
  • Contact

NEWS

CrossRoads invests in the cooperation between FOx Biosystems and Unitron Group BV

3/2/2020

 
CrossRoads, part of the European program Interreg, stimulates cross-border cooperation between Flanders and the Netherlands. Companies with innovative and strong project ideas qualify for financial support. FOx Biosystems handed in a project proposal, together with Unitron Group BV and Stimulus, two Dutch companies.
Picture
The first part of the project focuses on an upgraded version of the current White FOx. The purpose is to build a more robust device with higher throughput, and which can in addition be easily coupled to other existing tools (e.g. liquid handlers, test bioreactors, ...). Next, we will develop generic tests, like the 'host cell protein' assay, which measures the fragment concentration of unwanted by-products during pharmaceutical drug manufacturing. This information is essential for antibody producers to determine the quality of a drug and to follow the efficiency of the production process. With the support of CrossRoads, we will be able to optimize the 'time to result', detection limit, specificity, reproducibility and storage conditions.

This €299 000 project, which is supported for 45% by CrossRoads, started in January of 2020.
Picture

FOx Biosystems, in partnering with U Hasselt, receives €48 000 from European Union (Interreg TTD - PPL)

3/2/2020

 
Picture

​The high prevalence of cardiovascular diseases (CVD) has major implications in the Western society. Within the Interreg Vlaanderen-Nederland project, Trans Tech Diagnostics (TTD) focuses on innovative research to develop improved cardiovascular diagnostics.
The research group of Prof. Dr. Luc Michiels, head of Immunology – Biochemistry at UHasselt (BIOMED), together with FOx Biosystems as a Project Partner light (PPL), investigates the development of a novel diagnostic method to better evaluate the risk factors of developing CVD. During this project, a new prototype (demonstrator) of SPR optical fibers and measuring robot will be developed, which enables the concentration measurement of specific inflammatory biomarkers in patients with potential risk for CVD. FOx Biosystems will vouch for exchanging data and knowledge within the TTD project.

The project will be supported by Interreg TTD through a public private partnership for €48 000. The optimization of the demonstrator will be accomplished by focusing on three main points: 1) production of the gold coated optical fibers, 2) assurance of immobilization reproducibility of affinity molecules, and 3) demonstration of high sample sensitivity.
Picture
Picture
Picture

    Author

    FOx Biosystems news

    Archives

    September 2020
    June 2020
    March 2020
    February 2020
    October 2019
    September 2019
    July 2019
    February 2019
    July 2018
    May 2018
    April 2018
    February 2018
    August 2017

    Categories

    All
    General

    RSS Feed

contact form

open the contact form here

Email

info@foxbiosystems.com
Terms of use
  • Home
  • Technology
    • Technology
    • Proteins and antibodies
    • Crude Samples
    • Bioprocess
    • Cells and Microvesicles
    • Other Applications
  • Products and services
    • Products and services
    • White FOx 1.0
    • Services
  • ABOUT FOX
    • The company
    • Projects and Partnerships >
      • Link2Innovate
    • Management and founders
    • Careers >
      • Manufacturing Technician Biosensors
  • NEWS
  • Contact